Keimyung University Reports Findings in Cancer (Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy)

Press/Media: Research

PeriodJul 5 2023

Media coverage

1

Media coverage